Worldwide Regulatory Affairs and Quality Assurance (WRAQA) makes significant contributions to Pfizer's development of new medicinal products.
WRAQA is responsible for managing the interactions between the company and the regulatory authorities, advising project teams on successful development strategies, ensuring compliance with regulations, interpreting the emerging safety profile of drugs in development, producing high quality submissions, and accessing and influencing the emerging regulatory environment. Our mission is to be the most respected global regulatory affairs group in the industry as judged by our customers.